Long-term outcomes of salvage high-dose-rate brachytherapy for localized recurrence of prostate cancer following definitive radiation therapy: a retrospective analysis
Salvage HDR-BT without ADT is a safe and effective treatment option for localized prostate cancer recurrence after definitive radiation therapy. It provides excellent CSS rates with acceptable toxicity while potentially reducing the need for ADT. Further prospective studies are warranted to confirm these findings.
Authors
- Kenta Watanabe (ORCID: https://orcid.org/0000-0001-7301-1307)
- Yoshiyuki Miyaji (ORCID: https://orcid.org/0009-0006-9995-565X)
- Takafumi Hayashi (ORCID: https://orcid.org/0000-0002-8421-0253)
- Naoki Ikeda (ORCID: https://orcid.org/0000-0003-2072-0163)
- Tsutomu Tamada (ORCID: https://orcid.org/0000-0003-2521-9570)
- Ryoji Tokiya
- Kuniaki Katsui (ORCID: https://orcid.org/0000-0002-1842-2485)
- Nobuhiko Kamitani (ORCID: https://orcid.org/0009-0001-4872-7394)
- Yujiro Kawata (ORCID: https://orcid.org/0000-0002-6800-0715)
Institutions
- Kawasaki Medical School (JP)
- Okayama University Hospital (JP)
Publication Details
- Journal
- BMC Cancer
- Published
- 2025-03-22
- DOI
- https://doi.org/10.1186/s12885-025-13918-2
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00